Although there are technologies in the market to test for B_T, it is well established in the scientific literature that clinicians require additional data including B_f, BTmax, and KA to properly diagnose and treat newborns with hyperbilirubinemia. NeoMetrix Dx, Inc.’s in-vitro medical diagnostic device AL4 Dx offers:

• The first automated test available to clinicians that provides the critical biomarker Bf as well as B_T
• The first and only automated test (patented technology) available to clinicians that provides them with the crucial binding data BTmax and KA